Probiotics’ Part II: In Sickness and in Health

6 Oct 2014

by GMFH Editing Team

In a previous GMFH article, ‘PROBIOTICS’ PART I: A BRANCHING DEFINITION, we covered recent updates to the definition of probiotics as discussed at the October 2013 meeting organized by The International Scientific Association for Probiotics and Prebiotics (ISAPP). Three of

Probiotics’ Part I: A branching definition

24 Sep 2014

by GMFH Editing Team

Probiotics have a well-known definition that has been cited for over a decade: ‘Live microorganisms which when administered in adequate amounts confer a health benefit on the host’. Written in a 2001 joint report of the Food and Agriculture Organization

Sweeteners, glucose metabolism and gut microbiota

18 Sep 2014

by GMFH Editing Team

Researchers from Israel recently published in Nature how NAS [Non-caloric artificial sweeteners] affect glucose tolerance. In an initial experiment, researchers found mice that consumed water, glucose, or sucrose had comparable glucose tolerance curves, but all 3 mouse groups consuming NAS

Patrick Veiga and MetaHIT colleagues tested how fermented milks product could modulate microbiota. Using a metagenomics approach, they found that the abundance of unknown species increased in the gut when patients took the fermented milk product. Having access to the

Interview with INRA’s Marion Leclerc

29 Aug 2014

by Kristina Campbell

Marion Leclerc is a French microbiologist working at INRA  (the French National Institute for Agricultural Research) Jouy-en-Josas Centre. She spoke with Gut Microbiota for Health about her various areas of research. Research group of Marion Leclerc   What research are

Numerous commensal bacteria present in the gut microbiota produce short chain fatty acids (SCFA’s) particularly acetate, butyrate and propionate. These SCFA’s have been associated with several biological effects upon host. Growing evidence suggests that specific microbes such as Faecalibacterium prausnitzii

Lawrence and colleagues tracked two subjects' microbiota over a year, collecting 800 fecal and saliva samples associated with 10,000 longitudinal measurements. They first highlighted the evidence for long-term, overall community stability, as differences between individuals were much larger than variation within

Prof. Patrice Cani, of Belgium’s Université catholique de Louvain, is involved in the Metabolism and Nutrition research group of the Louvain Drug Research Institute. He investigates the role of the gut microbiota in the development of metabolic disorders: obesity, type